| Code | CSB-RA023978MB7HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to reference antibody SIM1811-03, targeting TNFRSF1B (Tumor Necrosis Factor Receptor Superfamily Member 1B), also known as TNFR2 or CD120b. TNFRSF1B is a cell surface receptor that binds tumor necrosis factor-alpha (TNF-α) and plays a crucial role in immune regulation, inflammatory responses, and cell survival signaling. Unlike TNFRSF1A, which primarily mediates pro-inflammatory and apoptotic signals, TNFRSF1B predominantly activates anti-apoptotic pathways and promotes tissue repair. This receptor is implicated in various pathological conditions including autoimmune diseases, chronic inflammation, cancer progression, and neurodegenerative disorders, where its expression on regulatory T cells and certain tumor cells contributes to immune modulation.
SIM1811-03 serves as the reference standard for this biosimilar product, providing researchers with a cost-effective alternative for investigating TNFRSF1B biology and its therapeutic potential. This antibody is valuable for studies examining TNF signaling pathways, immune cell regulation, and the differential roles of TNF receptors in disease pathogenesis.
There are currently no reviews for this product.